CATALOGO DEI PRODOTTI DELLA RICERCA

COLOMBATTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.667
EU - Europa 7.046
AS - Asia 4.402
SA - Sud America 695
AF - Africa 65
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.513
RU - Federazione Russa 2.383
GB - Regno Unito 2.175
SG - Singapore 1.855
CN - Cina 1.448
BR - Brasile 589
SE - Svezia 472
HK - Hong Kong 404
FI - Finlandia 363
DE - Germania 361
IE - Irlanda 343
FR - Francia 338
IT - Italia 254
VN - Vietnam 237
UA - Ucraina 121
KR - Corea 103
CA - Canada 87
IN - India 59
TR - Turchia 59
JP - Giappone 51
BE - Belgio 45
MX - Messico 45
AR - Argentina 43
NL - Olanda 41
ES - Italia 36
BD - Bangladesh 30
IR - Iran 29
ZA - Sudafrica 28
PL - Polonia 26
IQ - Iraq 23
ID - Indonesia 21
AT - Austria 18
EC - Ecuador 14
CO - Colombia 13
LT - Lituania 11
VE - Venezuela 10
AU - Australia 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
AZ - Azerbaigian 7
PH - Filippine 7
UY - Uruguay 7
UZ - Uzbekistan 7
CL - Cile 6
CZ - Repubblica Ceca 6
PA - Panama 6
PE - Perù 6
PK - Pakistan 6
PT - Portogallo 6
EG - Egitto 5
IL - Israele 5
RO - Romania 5
AL - Albania 4
CI - Costa d'Avorio 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
LV - Lettonia 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HR - Croazia 3
KZ - Kazakistan 3
MY - Malesia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CM - Camerun 2
CY - Cipro 2
DK - Danimarca 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
IS - Islanda 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BT - Bhutan 1
CG - Congo 1
CR - Costa Rica 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
Totale 19.873
Salva come PNG Salva come JPEG
Città #
Southend 1.866
Jacksonville 1.013
Singapore 907
Chandler 875
Moscow 775
Dallas 755
Woodbridge 723
Ashburn 609
Ann Arbor 489
Hong Kong 395
Dublin 343
Houston 269
Beijing 259
Los Angeles 202
Buffalo 169
Wilmington 150
New York 137
Lawrence 132
Princeton 132
Jinan 122
The Dalles 121
Nanjing 112
Shenyang 101
Helsinki 88
Ho Chi Minh City 83
Verona 83
Tianjin 75
Munich 67
Boardman 65
Hebei 64
Columbus 57
Hanoi 53
Seattle 53
São Paulo 51
Brussels 45
Changsha 44
Santa Clara 42
Sindelfingen 42
Tokyo 42
Zhengzhou 42
Milan 38
Taizhou 37
Ningbo 34
Cambridge 33
Montreal 32
Nanchang 32
Fairfield 31
Hangzhou 31
Guangzhou 30
Haikou 30
Jiaxing 30
San Francisco 30
Philadelphia 29
Seoul 29
Turku 29
Denver 27
Falls Church 27
London 25
Norwalk 25
San Jose 24
Taiyuan 24
Stockholm 23
Brooklyn 22
Fuzhou 22
Warsaw 22
Chennai 20
Johannesburg 20
Amsterdam 19
Redondo Beach 19
Auburn Hills 18
Council Bluffs 18
Lancaster 18
Chicago 17
Rio de Janeiro 17
Atlanta 16
Falkenstein 15
Frankfurt am Main 15
Lanzhou 15
Belo Horizonte 14
Bologna 14
Jakarta 14
Poplar 14
Boston 13
Brasília 12
Montréal 12
Nuremberg 12
Orem 12
Phoenix 12
Redwood City 12
Detroit 11
Mexico City 11
Biên Hòa 10
Shanghai 10
Augusta 9
Da Nang 9
Edinburgh 9
Kent 9
Manchester 9
New Delhi 9
Porto Alegre 9
Totale 12.841
Salva come PNG Salva come JPEG
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 277
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 261
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 250
Anti PSMA immunotoxins activity against prostate cancer cell lines. 246
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 246
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment 226
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 224
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates 222
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 217
Immunotoxins and other conjugates: preparation and general characteristics. 212
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 211
Anti-PSMA-Immunotoxins: a new therapeutical strategy for selective targeting of toxins to prostate cancer cells. 210
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 210
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 210
Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model 205
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 204
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 195
Cooperation of Prostate Specific Membrane Antigen with beta 1 integrin promotes the survival of aggressive prostate cancer cells 193
Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model 190
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 189
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events 187
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 187
A fluorescence-based assay for the reductase activity of protein disulfide isomerase. 186
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 186
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 185
Reductive activation of ricin and ricin-A chain immunotoxins by Protein Disulfide Isomerase and Thioredoxin Reductase system. 184
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 184
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 182
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 179
Disposition of intrathecally administered immunotoxins in rats. A preliminary report 178
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 178
Human immune response to ricin A-chain: identification of T-cell and B-cell epitopes. 174
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 174
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 172
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 172
Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity 170
Fluorescent Assay to Demonstrate the Interaction of Thioredoxin Reductase and Protein Disulfide Isomerase. 169
Characterization of In-111-labeled site-specifically conjugated anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors 169
Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin 167
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 167
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 167
Monoclonal antibodies against ricin: effects on toxin function 166
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 166
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 165
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 165
Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors 164
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 164
Anti-TNF? therapy in rheumatoid arthritis and autoimmunity 164
T cell immune function in newborn infants 162
N-terminal deletion affetcs catalytic activity of saporin toxin. 160
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection 158
Reductive activation of type 2 ribosome inactivating proteins (RIPs 2) is promoted by transmembrane thioredoxin-related protein (TMX) 158
The Filamin A-mediated cooperation of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin promotes the survival of aggressive prostate cancer cells. 158
Standardization of in vitro synthesis and detection of HIV-1-specific antibodies 157
Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol 157
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 157
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 155
Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. 155
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 154
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 154
Problems and potentials in immunotoxin therapy 153
Protein Disulfide Isomerase and Thioredoxin Reductase: a ricin disulfide reducing system in the endoplasmic reticulum. 152
FLUORESCENT ASSAY TO TEST PROTEIN DISULFIDE ISOMERASE ACTIVITY INDUCED BY THIOREDOXIN REDUCTASE. 152
Cloning and characterisation of canine prostate-specific membrane antigen 152
Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen 151
Human glioma cell lines: tumour associated antigens distribution and sensitivity to antibody-toxin or ligand-toxin conjugates. A preliminary report 150
Potentiation of cytotoxic heteroconjugates by monensin-carrier proteins 150
Prostate-specific membrane antigen associates already in the endoplasmic reticulum with lipid microdomains 150
Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines 149
The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells. 148
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas 147
IL-6 gene expression in human astrocytes is enhanced after adhesion to MBP-specific T-cells: role of beta1 integrin and IFN-gamma in the induction of NF-kB and IRF-1 binding activity 147
Lymphocyte phenotypic subsets in umbilical cord blood compared to peripheral blood from related mothers 146
Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen 145
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response in vitro. 145
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 145
Sensitivity of human glioma cells to cytotoxic heteroconjugates 143
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 143
Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin 142
Prostate Specific Membrane Antigen (PSMA) associates with Filamin A, beta1 integrin, pp130CAS and pSrc thus regulating the activation of beta1 integrin and the survival of prostate cancer cells. 142
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors 142
Lipid interaction of diphtheria toxin and mutants with altered fragment B. 2. Hydrophobic photolabelling and cell intoxication 141
Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells 140
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 140
Prostate-specific membrane antigen (PSMA) associates early in the endoplasmic reticulum with lipid microdomains 138
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 138
Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates 136
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 136
Magneto-Plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging 136
SERS IMAGING OF CANCER CELLS WITH ANTIBODY FUNCTIONALIZED GOLD NANOPARTICLES 135
Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA) 135
Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures 132
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 132
Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry 131
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 129
Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems. 129
Targeted Silica Nanoparticles for PhotoDynamic Therapy (PDT) 127
Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. 121
Human large granular lymphocytes contain an esterase activity usually considered as specific for the myeloid series 121
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 119
Totale 16.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.912
article - articoli 42.498
book - libri 0
conference - conferenze 14.676
curatela - curatele 0
other - altro 0
patent - brevetti 867
selected - selezionate 0
volume - volumi 1.871
Totale 119.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 155 13 110 91 13 191 54
2021/20221.157 111 308 6 99 39 36 29 78 43 29 110 269
2022/20232.478 175 230 210 402 239 577 89 200 262 12 61 21
2023/2024991 55 93 82 134 111 144 30 71 13 80 124 54
2024/20253.027 176 201 65 466 209 126 185 124 469 191 260 555
2025/20265.926 598 528 868 1.340 2.148 444 0 0 0 0 0 0
Totale 19.963